James E. MacDougall

4.2k total citations · 1 hit paper
58 papers, 2.8k citations indexed

About

James E. MacDougall is a scholar working on Gastroenterology, Surgery and Molecular Biology. According to data from OpenAlex, James E. MacDougall has authored 58 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Gastroenterology, 24 papers in Surgery and 9 papers in Molecular Biology. Recurrent topics in James E. MacDougall's work include Gastrointestinal motility and disorders (29 papers), Intestinal Malrotation and Obstruction Disorders (12 papers) and Congenital gastrointestinal and neural anomalies (11 papers). James E. MacDougall is often cited by papers focused on Gastrointestinal motility and disorders (29 papers), Intestinal Malrotation and Obstruction Disorders (12 papers) and Congenital gastrointestinal and neural anomalies (11 papers). James E. MacDougall collaborates with scholars based in United States, India and United Kingdom. James E. MacDougall's co-authors include Jeffrey M. Johnston, Mark G. Currie, Caroline B. Kurtz, Bernard J. Lavins, Anthony Lembo, Donald A. Fitch, Steven J. Shiff, Shrikant I. Bangdiwala, Vangie A. Foshee and Fletcher Linder and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and Neurology.

In The Last Decade

James E. MacDougall

53 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Linaclotide for Irritable Bowel Syndrome With Constipation: A 26-Week, Randomized, Double-blind, Placebo-Controlled Trial to Evaluate Efficacy and Safety

2012 340 citations William D. Chey, Anthony Lembo et al. The American Journal of Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James E. MacDougall United States	20	1.5k	1.1k	438	354	222	58	2.8k
Donghao Lu Sweden	31	82 0.1×	420 0.4×	59 0.1×	86 0.2×	10 0.0×	174	3.7k
David J. Kearney United States	27	222 0.1×	465 0.4×	53 0.1×	57 0.2×	8 0.0×	44	2.9k
Yali Zhang China	18	179 0.1×	332 0.3×	173 0.4×	41 0.1×	6 0.0×	55	1.6k
Annelie Carlsson Sweden	36	1.5k 1.0×	2.2k 2.0×	8 0.0×	139 0.4×	8 0.0×	132	4.2k
Michelle M. Smith United States	26	20 0.0×	673 0.6×	41 0.1×	250 0.7×	11 0.0×	70	2.3k
John J. Miller United States	32	28 0.0×	252 0.2×	93 0.2×	267 0.8×	15 0.1×	117	3.7k
David M. Thompson United States	25	11 0.0×	181 0.2×	215 0.5×	170 0.5×	11 0.0×	89	2.1k
Hyun Joon Shin South Korea	26	23 0.0×	229 0.2×	97 0.2×	585 1.7×	3 0.0×	65	4.5k
Anna Holmberg Sweden	33	67 0.0×	629 0.6×	10 0.0×	189 0.5×	2 0.0×	71	3.5k
Mayumi Yamamoto Japan	24	10 0.0×	273 0.2×	30 0.1×	220 0.6×	14 0.1×	168	2.2k

Countries citing papers authored by James E. MacDougall

Since Specialization

Citations

This map shows the geographic impact of James E. MacDougall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. MacDougall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. MacDougall more than expected).

Fields of papers citing papers by James E. MacDougall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James E. MacDougall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. MacDougall. The network helps show where James E. MacDougall may publish in the future.

Co-authorship network of co-authors of James E. MacDougall

This figure shows the co-authorship network connecting the top 25 collaborators of James E. MacDougall. A scholar is included among the top collaborators of James E. MacDougall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James E. MacDougall. James E. MacDougall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dufton, Christopher, Marc Evanchik, David G. Daniel, et al.. (2025). EDG-7500, A First-in-Class Cardiac Sarcomere Modulator, Demonstrates Favorable Tolerability, Safety, And Pharmacokinetics In Healthy Adults. Journal of Cardiac Failure. 31(1). 345–345. 3 indexed citations

Donovan, J., et al.. (2024). 351P Sevasemten, a fast myosin inhibitor, in adults with Becker muscular dystrophy results in reduced muscle damage biomarkers and functional stabilization. Neuromuscular Disorders. 43. 104441.682–104441.682.

O’Dea, Louis, James E. MacDougall, Veronica J. Alexander, et al.. (2019). Differentiating Familial Chylomicronemia Syndrome From Multifactorial Severe Hypertriglyceridemia by Clinical Profiles. Journal of the Endocrine Society. 3(12). 2397–2410. 42 indexed citations

Finkel, Richard S., Krista Vandenborne, H. Lee Sweeney, et al.. (2019). Edasalonexent, an NF-kB Inhibitor, Slows Longer-Term Disease Progression on Multiple Functional and MRI Assessments Compared to Control Period in 4 to 7-Year Old Patients with Duchenne Muscular Dystrophy (S51.006). Neurology. 92(15_supplement). 2 indexed citations

Kumar, Deepali, Peter Chin‐Hong, Liise K. Kayler, et al.. (2019). A prospective multicenter observational study of cell-mediated immunity as a predictor for cytomegalovirus infection in kidney transplant recipients. American Journal of Transplantation. 19(9). 2505–2516. 83 indexed citations

MacDougall, James E., et al.. (2017). Utility of the T-SPOT®.TB test's borderline category to increase test resolution for results around the cut-off point. Tuberculosis. 108. 178–185. 14 indexed citations

Chey, William D., Bernard J. Lavins, Steven J. Shiff, et al.. (2014). PWE-166 Is Response To Linaclotide After 4 Weeks Of Treatment Predictive Of 12-week Improvement?. Gut. 63(Suppl 1). A197.2–A198.

Camilleri, Michael, Anthony Lembo, Bernard J. Lavins, et al.. (2014). Comparison of adequate relief with symptom, global, and responder endpoints in linaclotide phase 3 trials in IBS‐C. United European Gastroenterology Journal. 3(1). 53–62. 11 indexed citations

Castro, Joel, Andrea M. Harrington, Patrick A. Hughes, et al.. (2013). Linaclotide Inhibits Colonic Nociceptors and Relieves Abdominal Pain via Guanylate Cyclase-C and Extracellular Cyclic Guanosine 3′,5′-Monophosphate. Gastroenterology. 145(6). 1334–1346.e11. 228 indexed citations

10.

Rao, Satish S.C., Eamonn M.M. Quigley, Steven J. Shiff, et al.. (2013). Effect of Linaclotide on Severe Abdominal Symptoms in Patients With Irritable Bowel Syndrome With Constipation. Clinical Gastroenterology and Hepatology. 12(4). 616–623. 51 indexed citations

11.

Rao, Satish S.C., Anthony Lembo, Steven J. Shiff, et al.. (2012). A 12-Week, Randomized, Controlled Trial With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Linaclotide in Irritable Bowel Syndrome With Constipation. The American Journal of Gastroenterology. 107(11). 1714–1724. 293 indexed citations

12.

Chey, William D., Anthony Lembo, Bernard J. Lavins, et al.. (2012). Linaclotide for Irritable Bowel Syndrome With Constipation: A 26-Week, Randomized, Double-blind, Placebo-Controlled Trial to Evaluate Efficacy and Safety. The American Journal of Gastroenterology. 107(11). 1702–1712. 340 indexed citations breakdown →

13.

MacDougall, James E., David P. MacKinnon, Bernard J. Lavins, et al.. (2012). Sa1098 Mediation Analysis Supports a Direct Effect of Linaclotide on Relief of Abdominal Pain Independent of Constipation Improvement. Gastroenterology. 142(5). S–215. 4 indexed citations

14.

Lembo, Anthony, Harvey Schneier, Steven J. Shiff, et al.. (2011). Two Randomized Trials of Linaclotide for Chronic Constipation. New England Journal of Medicine. 365(6). 527–536. 270 indexed citations

15.

Johnston, Jeffrey M., Caroline B. Kurtz, James E. MacDougall, et al.. (2010). Linaclotide Improves Abdominal Pain and Bowel Habits in a Phase IIb Study of Patients With Irritable Bowel Syndrome With Constipation. Gastroenterology. 139(6). 1877–1886.e2. 177 indexed citations

16.

Lembo, Anthony, Caroline B. Kurtz, James E. MacDougall, et al.. (2010). Efficacy of Linaclotide for Patients With Chronic Constipation. Gastroenterology. 138(3). 886–895.e1. 170 indexed citations

17.

Lavins, Bernard J., Jeffrey M. Johnston, James E. MacDougall, et al.. (2009). 418 Effect of Linaclotide On Quality of Life in Adults with Chronic Constipation: Results from a Phase 2B Study. Gastroenterology. 136(5). A–71. 1 indexed citations

18.

Johnston, Jeffrey M., Caroline B. Kurtz, Douglas A. Drossman, et al.. (2008). Pilot Study on the Effect of Linaclotide in Patients With Chronic Constipation. The American Journal of Gastroenterology. 104(1). 125–132. 93 indexed citations

19.

Edwards, Lloyd J., Paul W. Stewart, James E. MacDougall, & Ronald W. Helms. (2005). A method for fitting regression splines with varying polynomial order in the linear mixed model. Statistics in Medicine. 25(3). 513–527. 19 indexed citations

20.

Foshee, Vangie A., Fletcher Linder, James E. MacDougall, & Shrikant I. Bangdiwala. (2001). Gender Differences in the Longitudinal Predictors of Adolescent Dating Violence. Preventive Medicine. 32(2). 128–141. 328 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact